Anita Turk, MD, discusses what she is most excited about regarding immunotherapy in the realm of colorectal cancer treatment.

Anita Turk, MD, discusses the unmet needs that still exist in the realm of colorectal cancer treatment and management.

Patients in a structured exercise program experienced a 37% lower risk of death and a 28% reduction in recurrence or ...

Why and how does exercise reduce cancer risk, and what should everyone know about incorporating exercise programs in their ...

Chemo drugs commonly used to treat cervical cancer Treatment choices are made based on each person's needs. Drugs that have been used include: Cisplatin Carboplatin Bevacizumab (Avastin) Paclitaxel ...

Waiting about 9 months or more to rechallenge patients with amivantamab can improve outcomes in patients with colorectal cancer, data suggest.

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Before starting any systemic chemotherapy in advanced disease, testing for over expression of the H uman E pidermal growth factor R eceptor-2 (abbreviated HER-2) testing is mandatory, and people with ...

Colon cancer will be diagnosed in approximately 150,000 Americans in 2024. It’s the fourth most diagnosed cancer in the United States and one of the leading causes of cancer deaths, according to ...

For more information, see Colostomy Guide and Ileostomy Guide. Surgery for colon cancer spread If the cancer has spread to only one or a few spots (nodules) in the lungs or liver (and apparently ...